BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1
57 results:

  • 1. [Pathogenesis and Targeted Treatment Progress of Splenomegaly in Primary Myelofibrosis--Review].
    Chen ZW; Wang SX; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):308-312. PubMed ID: 38387940
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inherent genome instability underlies trisomy 21-associated myeloid malignancies.
    Chen CC; Silberman RE; Ma D; Perry JA; Khalid D; Pikman Y; Amon A; Hemann MT; Rowe RG
    Leukemia; 2024 Mar; 38(3):521-529. PubMed ID: 38245602
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study.
    Xing P; Zhao Q; Zhang L; Wang H; Huang D; Hu P; Sun Y; Shi Y
    BMC Med; 2022 Nov; 20(1):453. PubMed ID: 36424628
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Hematopoietic TALE-Code Shows Normal Activity of IRX1 in Myeloid Progenitors and Reveals Ectopic Expression of IRX3 and IRX5 in Acute Myeloid Leukemia.
    Nagel S; Pommerenke C; Meyer C; MacLeod RAF
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328612
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Post-induction MRD by FCM and gata1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome.
    Taga T; Tanaka S; Hasegawa D; Terui K; Toki T; Iwamoto S; Hiramatsu H; Miyamura T; Hashii Y; Moritake H; Nakayama H; Takahashi H; Shimada A; Taki T; Ito E; Hama A; Ito M; Koh K; Hasegawa D; Saito AM; Adachi S; Tomizawa D
    Leukemia; 2021 Sep; 35(9):2508-2516. PubMed ID: 33589754
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Treatment strategy for myeloid leukemia with Down syndrome].
    Taga T
    Rinsho Ketsueki; 2020; 61(9):1382-1387. PubMed ID: 33162539
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. gata1/SP1 and miR-874 mediate enterovirus-71-induced apoptosis in a granzyme-B-dependent manner in Jurkat cells.
    Zhang M; Chen Y; Cheng X; Cai Z; Qiu S
    Arch Virol; 2020 Nov; 165(11):2531-2540. PubMed ID: 32851429
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3', 5'-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells.
    Ma Y; Xu B; Yu J; Huang L; Zeng X; Shen X; Ren C; Ben-David Y; Luo H
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210104
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin lymphoma in children-A preliminary observation.
    M A; Chatterjee S; A P; S M; Davuluri S; Ar AK; T A; M P; Cs P; Sinha M; Chugani A; R VP; Kk A; R S J
    Immunobiology; 2020 May; 225(3):151907. PubMed ID: 32044149
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
    Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
    Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Highly sensitive detection of gata1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
    Terui K; Toki T; Taga T; Iwamoto S; Miyamura T; Hasegawa D; Moritake H; Hama A; Nakashima K; Kanezaki R; Kudo K; Saito AM; Horibe K; Adachi S; Tomizawa D; Ito E
    Genes Chromosomes Cancer; 2020 Mar; 59(3):160-167. PubMed ID: 31606922
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients.
    Xie Y; Gao L; Xu C; Chu L; Gao L; Wu R; Liu Y; Liu T; Sun XJ; Ren R; Tang J; Zheng Y; Zhou Y; Shen S
    Haematologica; 2020 Apr; 105(4):925-936. PubMed ID: 31467124
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Difference in megakaryocyte expression of GATA-1, IL-6, and IL-8 associated with maintenance of platelet counts in patients with plasma cell neoplasm with dysmegakaryopoiesis.
    Kim H; Lee MK; Kim HR
    Exp Hematol; 2019 May; 73():13-17.e2. PubMed ID: 30825517
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation.
    Simic D; Sang N
    Exp Hematol; 2019 Apr; 72():36-46. PubMed ID: 30611870
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ginsenoside F1 Promotes Cytotoxic Activity of NK Cells via Insulin-Like Growth Factor-1-Dependent Mechanism.
    Kwon HJ; Lee H; Choi GE; Kwon SJ; Song AY; Kim SJ; Choi WS; Hwang SH; Kim SC; Kim HS
    Front Immunol; 2018; 9():2785. PubMed ID: 30546365
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia.
    Song J; Yuan C; Yang J; Liu T; Yao Y; Xiao X; Gajendran B; Xu D; Li YJ; Wang C; Liu W; Wen M; Spaner D; Filmus J; Zacksenhaus E; Zhang Y; Hao X; Ben-David Y
    FEBS J; 2018 Dec; 285(24):4631-4645. PubMed ID: 30387554
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CREBBP/EP300 bromodomains are critical to sustain the gata1/MYC regulatory axis in proliferation.
    Garcia-Carpizo V; Ruiz-Llorente S; Sarmentero J; Graña-Castro O; Pisano DG; Barrero MJ
    Epigenetics Chromatin; 2018 Jun; 11(1):30. PubMed ID: 29884215
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2.
    Han Q; Xu X; Li J; Wang J; Bai L; Wang A; Wang W; Zhang B
    Mol Med Rep; 2017 Nov; 16(5):6290-6298. PubMed ID: 28849107
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. gata1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
    Lee WY; Weinberg OK; Pinkus GS
    Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.